Carolina Pulmonary Medicine is categorized under Pulmonary Doctors in Cary, NC and active since 2010.
Carolina Pulmonary Medicine was established in 2010, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Pulmonary Doctors business, which does work in the B2C market, and is classified as a Pulmonary Doctors, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact Alicia Solis, Office Manager at the company’s single location by writing to 200 Keisler Drive # C, Cary, North Carolina NC 27518 or by phoning (919) 233-0234. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Carolina Pulmonary Medicine |
| Contact Person: | Alicia Solis, Office Manager |
| Address: | 200 Keisler Drive # C, Cary, North Carolina 27518 |
| Phone Number: | (919) 233-0234 |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Pulmonary Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Carolina Pulmonary Medicine was started in 2010 to provide professional Pulmonary Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Alicia Solis, Office Manager for inquiries that concern Carolina Pulmonary Medicine by calling the company number (919) 233-0234, as your correspondence is most welcome. Additionally, the physical location of the single location of Carolina Pulmonary Medicine can be found at the coordinates 35.741,-78.779 as well as the street address 200 Keisler Drive # C in Cary, North Carolina 27518.
For its online presence, you may visit Carolina Pulmonary Medicine’s website at and engage with its social media outlets through on Twitter and on Facebook.